Explore more about: Cancer

February 16, 2021
News
Vascular and interventional radiologists report the development of a new ionic liquid formulation that killed cancer cells and allowed uniform distribution of a chemotherapy drug into liver tumors and other solid tumors in the lab. This discovery could solve a problem that has long plagued drug delivery to tumors.
October 26, 2020
News
A scientist and entrepreneur is working to use simple LED light to help determine if certain chemotherapy options will work for specific patients.
October 13, 2020
News
In a groundbreaking new study, researchers have 3D printed unique fluid channels at the micron scale that could automate production of diagnostics, sensors, and assays used for a variety of medical tests and other applications.
September 17, 2020
News
Researchers have created a new PET imaging agent that detects signs of inflammation. Such a tracer could aid diagnosis and study of diseases ranging from cardiovascular disease to cancer to COVID-19.
August 14, 2020
News
A team has developed a class of light-switchable, highly adaptable molecular tools with new capabilities to control cellular activities. The antibody-like proteins, called OptoBinders, have potential applications including protein purification, the improved production of biofuels, and new types of targeted cancer therapies.
August 14, 2020
News
NIBIB mourns the passing of molecular imaging pioneer and NIBIB Advisory Council member, Sanjiv “Sam” Gambhir, M.D., Ph.D.
August 3, 2020
News
NIBIB-funded researchers at Stanford University have created an artificial neural network that analyzes lung CT scans to provide information about lung cancer severity that can guide treatment options.
June 8, 2020
News
To counter drug resistance, scientists must engineer new drugs to kill mutated cancer cells or pathogens. Now, Penn State engineers have developed a new approach for predicting which mutation has expanded the most in a population and should be targeted to design the most effective new drug.
April 14, 2020
News
Bioengineers have combined standard microscopy, infrared light, and artificial intelligence to assemble digital biopsies that identify important molecular characteristics of cancer biopsy samples.
March 25, 2020
News
Whether it is a drug-resistant strain of bacteria, or cancer cells that no longer react to the drugs intended to kill them, diverse mutations make cells resistant to chemicals, and 'second generation' approaches are needed. Now, a team of engineers may have a way to predict which mutations will occur in people, creating an easier path to create effective pharmaceuticals.